Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2000
10/19/2000WO2000061622A2 Genes associated with diseases of the kidney
10/19/2000WO2000061621A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/19/2000WO2000061620A1 49 human secreted proteins
10/19/2000WO2000061619A1 Protein/polypeptide-k obtained from momordica charantia and a process for the extraction thereof
10/19/2000WO2000061616A1 Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients
10/19/2000WO2000061614A2 Uncoupling proteins
10/19/2000WO2000061613A2 Channel forming toxins as antiviral agents
10/19/2000WO2000061612A2 Compounds and methods for therapy and diagnosis of lung cancer
10/19/2000WO2000061610A2 Prostate-restricted gene 30p3c8 expressed in prostate cancer
10/19/2000WO2000061609A2 Prodrugs of thrombin inhibitors
10/19/2000WO2000061608A2 Low-molecular inhibitors of complement proteases
10/19/2000WO2000061607A1 Separation of plasma components
10/19/2000WO2000061605A1 Dna encoding the prostate-specific membrane antigen-like gene and uses thereof
10/19/2000WO2000061602A1 Antisense oligonucleotide modulation of stat3 expression
10/19/2000WO2000061601A1 ANTISENSE MODULATION OF G-ALPHA-i1 EXPRESSION
10/19/2000WO2000061600A1 Antisense modulation of smad3 expression
10/19/2000WO2000061599A1 Antisense modulation of microtubule-associated protein 4 expression
10/19/2000WO2000061598A2 Rat kidney specific gene profilin-3
10/19/2000WO2000061596A1 50 human secreted proteins
10/19/2000WO2000061577A1 Prodrugs of thrombin inhibitors
10/19/2000WO2000061574A2 Method for producing thiophenyl-amidines
10/19/2000WO2000061542A1 Caspase inhibitors and the use thereof
10/19/2000WO2000061541A2 Pharmaceutical compounds
10/19/2000WO2000061537A2 Pharmaceutical compounds
10/19/2000WO2000061230A2 Estrogen receptors-beta antagonism and bone diseases
10/19/2000WO2000061204A1 Three-dimensional stromal tissue
10/19/2000WO2000061195A1 Benzodiazepine derivatives for imaging thrombi
10/19/2000WO2000061193A1 Antisense modulation of mdmx expression
10/19/2000WO2000061189A2 Water-soluble compositions of bioactive lipophilic compounds
10/19/2000WO2000061185A1 Docetaxel in combination with rhumab her2 for the treatment of cancers
10/19/2000WO2000061182A2 Methods and compositions for the treatment and prevention of lung disease involving a selective rar-alpha agonist
10/19/2000WO2000061180A2 Products and methods for treating ptp lar related diseases
10/19/2000WO2000061179A1 Kringle domains of plasminogen, capable of modulating angiogenesis in vivo
10/19/2000WO2000061178A1 Pulmonary administration of dry powder formulations for treating infertility
10/19/2000WO2000061177A1 Composition based on oppositely-charged polypeptides
10/19/2000WO2000061176A2 Treatment of multiple sclerosis with a combination of interferon and growth hormone
10/19/2000WO2000061175A2 Use of pegylated interferon alpha in melanoma therapy
10/19/2000WO2000061174A2 Use of pegylated interferon alpha for renal cell carcinoma treatment
10/19/2000WO2000061173A2 Use of pegylated interferon alpha in chronic myeloid leukemia (cml) therapy
10/19/2000WO2000061172A1 Interferon-beta use in the treatment of ewing's family of tumors
10/19/2000WO2000061171A2 Uses of mammalian ox2 protein and related reagents
10/19/2000WO2000061170A2 Novel medical use of alpha-1-acidic glycoprotein (aag or orosomucoid)
10/19/2000WO2000061169A1 Pharmaceutical compositions of erythropoietin
10/19/2000WO2000061168A1 Ocular treatment using cyclosporin-a derivatives
10/19/2000WO2000061167A2 TREATMENT OF MYELOMA BONE DISEASE WITH PROTEASOMAL AND NF-λB ACTIVITY INHIBITORS
10/19/2000WO2000061165A1 Conserved adhesin motif and methods of use thereof
10/19/2000WO2000061164A1 Modulation of excitable tissue function by peripherally administered erythropoietin
10/19/2000WO2000061150A1 Antisense modulation of fas mediated signaling
10/19/2000WO2000061142A1 Method and composition for the treatment of cancer
10/19/2000WO2000061132A1 Compositions containing immunotoxins and agents that inhibit dendritic cell maturation for inducing immune tolerance to a graft
10/19/2000WO2000061121A2 Use of molecular weight-amplified hirudin as an anticoagulant in extracorporeal renal replacement therapy
10/19/2000WO2000061069A2 Methods and compositions for use in the treatment of hyperlipidemia
10/19/2000WO2000061067A2 Anti-hiv 1 vaccine comprising the entire or part of the tat hiv-1 protein
10/19/2000WO2000060956A1 Hydrogel-forming system with hydrophobic and hydrophilic components
10/19/2000WO2000060945A1 SOLUBLE RECOMBINANT ENDOSTATIN AND METHOD OF MAKING SAME FROM $i(STREPTOMYCES SP)
10/19/2000WO2000060943A1 Prevention of brain damage in stroke
10/19/2000WO2000060932A1 Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in dna encoding 4e-bp1
10/19/2000WO2000049991A3 Treatment of trauma
10/19/2000WO2000039290A8 Pharmaceutical formulation containing a microbial enzyme which digests hyaluronic acid
10/19/2000WO2000039280A8 Leukocyte-derived interferon preparations
10/19/2000WO2000037641A3 Vascular endothelial growth factor-x
10/19/2000WO2000035952A3 Compounds for control of eating, growth and body weight
10/19/2000WO2000035475A3 Method for the treatment of cerebral ischaemia and use of erythropoietin or erythropoietin derivatives for the treatment of cerebral ischaemia
10/19/2000WO2000034780A3 METHODS AND COMPOSITIONS USEFUL FOR TARGETING ACTIVATED VITRONECTIN RECEPTOR αvβ¿3?
10/19/2000WO2000034485A3 Beta-1,3-galactosyltransferase homologs
10/19/2000WO2000034308A3 Protein transduction system and methods of use thereof
10/19/2000WO2000033872A3 Method of and compositions for immunization with the pseudomonas v antigen
10/19/2000WO2000032778A3 Methods and compositions for inhibiting neoplastic cell growth
10/19/2000WO2000032769A3 Mage-10 or mage-8 derived hla-a2.1-binding oligopeptides
10/19/2000WO2000032224A3 Calcitonin for the modulation of sperm function
10/19/2000WO2000032223A3 Therapeutic treatment with immunogenic drugs
10/19/2000WO2000031279A3 Producing antimicrobial cationic peptides as fusion proteins
10/19/2000WO2000031264A3 Testis-specific cystatin-like protein cystatin t
10/19/2000WO2000030669A3 Use of plasma phospholipid transfer proteins in treating cardiovascular dieases
10/19/2000WO2000029550A9 Low oxygen culturing of central nervous system progenitor cells
10/19/2000WO2000026368A9 Therapeutic antiangiogenic endostatin compositions
10/19/2000WO2000023625A3 Isolated nucleic acid molecules which encode scp proteins, and uses thereof
10/19/2000WO2000019883A9 Compositions and methods of disease diagnosis and therapy
10/19/2000WO2000013702A9 Use of an angiogenic factor for the treatment of microvascular angiopathies
10/19/2000WO2000012720A8 Elongase genes and uses thereof
10/19/2000DE19917084A1 Inhibiting cell cycle and cell growth, useful e.g. for protecting neuronal cells, by expressing an inhibitor of nuclear factor-kappaB in transdominant negative form
10/19/2000DE19915485A1 Therapie der Herzinsuffizienz Treatment of heart failure
10/19/2000DE19915465A1 Verwendung eines Caspase-Inhibitors zur Proliferationshemmung von Zellen und Verwendung eines oder mehrerer Caspase-Inhibitors/en zur Behandlung von Erkrankungen beruhend auf Lymphozyten-Hyperproliferation oder zur Suppression einer Immunantwort durch Lymphozyten Using a Caspase inhibitor for the inhibition of proliferation of cells and using one or more caspase inhibitor / s for the treatment of diseases based on lymphocyte hyperproliferation or for suppression of an immune response by lymphocytes
10/19/2000CA2760534A1 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
10/19/2000CA2383940A1 Modulation of excitable tissue function by peripherally administered erythropoietin
10/19/2000CA2382628A1 Compositions containing immunotoxins and agents that inhibit dendritic cell maturation for inducing immune tolerance to a graft
10/19/2000CA2372171A1 Benzodiazepine derivatives for imaging thrombi
10/19/2000CA2372028A1 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/19/2000CA2371223A1 49 human secreted proteins
10/19/2000CA2371172A1 50 human secreted proteins
10/19/2000CA2370767A1 49 human secreted proteins
10/19/2000CA2370563A1 Anti-hiv 1 vaccine comprising the entire or part of the tat hiv-1 protein
10/19/2000CA2370523A1 49 human secreted proteins
10/19/2000CA2370489A1 49 human secreted proteins
10/19/2000CA2370425A1 Pharmaceutical compounds
10/19/2000CA2370267A1 Prodrugs of thrombin inhibitors
10/19/2000CA2370237A1 Methods for the diagnosis and treatment of metastatic prostate tumors
10/19/2000CA2370189A1 48 human secreted proteins
10/19/2000CA2370131A1 62 human secreted proteins
10/19/2000CA2370112A1 Uncoupling proteins
1 ... 2334 2335 2336 2337 2338 2339 2340 2341 2342 2343 2344 2345 2346 2347 2348 2349 2350 2351 2352 2353 2354 ... 3163